跳至主要内容
临床试验/DRKS00024992
DRKS00024992尚未招募不适用

Prevalence of cardiac impairments after COVID-19

niversitätsklinikum Heidelberg0 个研究点目标入组 200 人开始时间: 2021年4月7日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Age of at least 18 years and ability to consent
  • - COVID-19 at least 4 months ago - proven by SARS-Cov-2 PCR or antibody test

排除标准

  • - Contraindications to MRI examinations - especially MRI incompatible implants, clinical instability and severe claustrophobia.
  • - Heart failure that existed prior to COVID-19
  • - Myocardial diseases (heart failure, cardiomyopathies, myocarditis) that existed prior to COVID-19
  • - Coronary artery disease, which requires or required coronary intervention and myocardial infarction.
  • - Prior cardiac surgery (e.g., bypass) and device implantation (e.g., heart valves, PFO occluders)
  • - Atrial fibrillation that existed prior to COVID-19
  • - Active cancer
  • - Pregnancy

研究者

发起方
niversitätsklinikum Heidelberg

相似试验